25 0 2 0 2 B-upper_bound
% 2 3 2 3 I-upper_bound
increase 4 12 4 12 O
in 13 15 13 15 O
bone 16 20 16 20 B-clinical_variable
marrow 21 27 21 27 I-clinical_variable
plasma 28 34 28 34 I-clinical_variable
cell 35 39 35 39 I-clinical_variable
percentage 40 50 40 50 O
from 51 55 51 55 O
lowest 56 62 56 62 O
response 63 71 63 71 O
value 72 77 72 77 O
during 78 84 78 84 O
( 85 86 85 86 O
or 86 88 86 88 O
after 89 94 89 94 O
) 94 95 94 95 O
last 96 100 96 100 B-treatment
therapy 101 108 101 108 I-treatment

25 0 2 109 111 B-lower_bound
% 2 3 111 112 I-lower_bound
increase 4 12 113 121 O
in 13 15 122 124 O
serum 16 21 125 130 O
FLC 22 25 131 134 B-clinical_variable
level 26 31 135 140 I-clinical_variable
from 32 36 141 145 O
the 37 40 146 149 O
lowest 41 47 150 156 O
response 48 56 157 165 O
value 57 62 166 171 O
during 63 69 172 178 O
( 70 71 179 180 O
or 71 73 180 182 O
after 74 79 183 188 O
) 79 80 188 189 O
last 81 85 190 194 O
therapy 86 93 195 202 B-treatment
- 94 95 203 204 O
the 96 99 205 208 O
absolute 100 108 209 217 O
increase 109 117 218 226 O
must 118 122 227 231 O
be 123 125 232 234 O
> 126 127 235 236 O
10 128 130 237 239 B-lower_bound
mg 131 133 240 242 I-lower_bound
/ 133 134 242 243 I-lower_bound
dL 134 136 243 245 I-lower_bound

25 0 2 246 248 O
% 2 3 248 249 O
increase 4 12 250 258 O
in 13 15 259 261 O
serum 16 21 262 267 O
M 22 23 268 269 O
- 23 24 269 270 O
protein 24 31 270 277 O
from 32 36 278 282 O
lowest 37 43 283 289 O
response 44 52 290 298 O
value 53 58 299 304 O
during 59 65 305 311 O
( 66 67 312 313 O
or 67 69 313 315 O
after 70 75 316 321 O
) 75 76 321 322 O
last 77 81 323 327 O
therapy 82 89 328 335 B-treatment

25 0 2 336 338 B-lower_bound
% 2 3 338 339 I-lower_bound
increase 4 12 340 348 O
in 13 15 349 351 O
urine 16 21 352 357 B-clinical_variable
M 22 23 358 359 I-clinical_variable
- 23 24 359 360 I-clinical_variable
protein 24 31 360 367 I-clinical_variable
from 32 36 368 372 O
lowest 37 43 373 379 O
response 44 52 380 388 O
value 53 58 389 394 O
during 59 65 395 401 O
( 66 67 402 403 O
or 67 69 403 405 O
after 70 75 406 411 O
) 75 76 411 412 O
last 77 81 413 417 O
therapy 82 89 418 425 B-treatment

ALT 0 3 426 429 B-clinical_variable
> 4 5 430 431 O
3 6 7 432 433 B-lower_bound
x 8 9 434 435 I-lower_bound
ULN 10 13 436 439 I-lower_bound

ANC 0 3 440 443 B-clinical_variable
< 4 5 444 445 O
1500 6 10 446 450 B-upper_bound
/ 10 11 450 451 I-upper_bound
uL 11 13 451 453 I-upper_bound

Anti 0 4 454 458 B-treatment
- 4 5 458 459 I-treatment
platelet 5 13 459 467 I-treatment
therapy 14 21 468 475 I-treatment

Any 0 3 476 479 O
other 4 9 480 485 O
concomitant 10 21 486 497 O
serious 22 29 498 505 B-chronic_disease
illness 30 37 506 513 I-chronic_disease
or 38 40 514 516 O
organ 41 46 517 522 B-chronic_disease
system 47 53 523 529 I-chronic_disease
dysfunction 54 65 530 541 I-chronic_disease
in 66 68 542 544 O
opinion 69 76 545 552 O
of 77 79 553 555 O
Investigator 80 92 556 568 O
would 93 98 569 574 O
either 99 105 575 581 O
compromise 106 116 582 592 O
subject 117 124 593 600 O
safety 125 131 601 607 O
or 132 134 608 610 O
interfere 135 144 611 620 O
with 145 149 621 625 O
test 150 154 626 630 O
drug 155 159 631 635 O
safety 160 166 636 642 O
evaluation 167 177 643 653 O

Bilirubin 0 9 654 663 B-clinical_variable
> 10 11 664 665 O
1.5 12 15 666 669 B-lower_bound
x 16 17 670 671 I-lower_bound
ULN 18 21 672 675 I-lower_bound

Bisphosphonates 0 15 676 691 B-treatment
and 16 19 692 695 O
denosumab 20 29 696 705 B-treatment
are 30 33 706 709 O
permitted 34 43 710 719 O
if 44 46 720 722 O
subject 47 54 723 730 O
has 55 58 731 734 O
been 59 63 735 739 O
receiving 64 73 740 749 O
for 74 77 750 753 O
at 78 80 754 756 O
least 81 86 757 762 O
90 87 89 763 765 B-lower_bound
days 90 94 766 770 I-lower_bound

Bone 0 4 771 775 B-treatment
marrow 5 11 776 782 I-treatment
biopsy 12 18 783 789 I-treatment
within 19 25 790 796 O
28 26 28 797 799 B-upper_bound
days 29 33 800 804 I-upper_bound
of 34 36 805 807 O
study 37 42 808 813 B-treatment
drug 43 47 814 818 I-treatment
infusion 48 56 819 827 I-treatment
demonstrating 57 70 828 841 O
at 71 73 842 844 O
least 74 79 845 850 O
5 80 81 851 852 B-lower_bound
% 81 82 852 853 I-lower_bound
plasma 83 89 854 860 O
cell 90 94 861 865 O
involvement 95 106 866 877 O

Chronic 0 7 878 885 B-treatment
immunosuppressive 8 25 886 903 I-treatment
therapy 26 33 904 911 I-treatment

Clinically 0 10 912 922 O
significant 11 22 923 934 O
bleeding 23 31 935 943 O
event 32 37 944 949 O
, 37 38 949 950 O
as 39 41 951 953 O
judged 42 48 954 960 O
by 49 51 961 963 O
investigator 52 64 964 976 O
, 64 65 976 977 O
within 66 72 978 984 O
prior 73 78 985 990 B-upper_bound
6 79 80 991 992 I-upper_bound
months 81 87 993 999 I-upper_bound

Eastern 0 7 1000 1007 B-clinical_variable
Cooperative 8 19 1008 1019 I-clinical_variable
Oncology 20 28 1020 1028 I-clinical_variable
Group 29 34 1029 1034 I-clinical_variable
performance 35 46 1035 1046 I-clinical_variable
status 47 53 1047 1053 I-clinical_variable
of 54 56 1054 1056 O
0 57 58 1057 1058 B-lower_bound
to 59 61 1059 1061 O
2 62 63 1062 1063 B-upper_bound

Estimated 0 9 1064 1073 B-clinical_variable
glomerular 10 20 1074 1084 I-clinical_variable
filtration 21 31 1085 1095 I-clinical_variable
rate 32 36 1096 1100 I-clinical_variable
< 37 38 1101 1102 O
30 39 41 1103 1105 B-upper_bound
mL 42 44 1106 1108 I-upper_bound
/ 44 45 1108 1109 I-upper_bound
min/1.73 45 53 1109 1117 I-upper_bound
m2 54 56 1118 1120 I-upper_bound

Extradural 0 10 1121 1131 O
tumor 11 16 1132 1137 B-cancer
in 17 19 1138 1140 O
contact 20 27 1141 1148 O
with 28 32 1149 1153 O
the 33 36 1154 1157 O
spinal 37 43 1158 1164 O
cord 44 48 1165 1169 O
or 49 51 1170 1172 O
tumor 52 57 1173 1178 O
located 58 65 1179 1186 O
where 66 71 1187 1192 O
swelling 72 80 1193 1201 O
in 81 83 1202 1204 O
response 84 92 1205 1213 O
to 93 95 1214 1216 O
therapy 96 103 1217 1224 B-treatment
may 104 107 1225 1228 O
impinge 108 115 1229 1236 O
upon 116 120 1237 1241 O
spinal 121 127 1242 1248 O
cord 128 132 1249 1253 O

Grade 0 5 1254 1259 B-lower_bound
2 6 7 1260 1261 I-lower_bound
or 8 10 1262 1264 O
greater 11 18 1265 1272 O
toxicities 19 29 1273 1283 O
due 30 33 1284 1287 O
to 34 36 1288 1290 O
previous 37 45 1291 1299 B-treatment
therapies 46 55 1300 1309 I-treatment
, 55 56 1309 1310 O
subject 57 64 1311 1318 O
to 65 67 1319 1321 O
laboratory 68 78 1322 1332 O
abnormalities 79 92 1333 1346 O
listed 93 99 1347 1353 O
below 100 105 1354 1359 O

Hemoglobin 0 10 1360 1370 B-clinical_variable
< 11 12 1371 1372 O
8 13 14 1373 1374 B-upper_bound
g 15 16 1375 1376 I-upper_bound
/ 16 17 1376 1377 I-upper_bound
dL 17 19 1377 1379 I-upper_bound

Histologically 0 14 1380 1394 O
or 15 17 1395 1397 O
cytologically 18 31 1398 1411 O
confirmed 32 41 1412 1421 O
multiple 42 50 1422 1430 B-cancer
myeloma 51 58 1431 1438 I-cancer

History 0 7 1439 1446 O
of 8 10 1447 1449 O
hypersensitivity 11 27 1450 1466 O
to 28 30 1467 1469 O
iodine 31 37 1470 1476 B-allergy_name

INR 0 3 1477 1480 B-clinical_variable
> 4 5 1481 1482 O
1.3 6 9 1483 1486 B-lower_bound

Known 0 5 1487 1492 O
history 6 13 1493 1500 O
of 14 16 1501 1503 O
HIV 17 20 1504 1507 B-chronic_disease
, 20 21 1507 1508 O
hepatitis 22 31 1509 1518 B-chronic_disease
C 32 33 1519 1520 I-chronic_disease
or 34 36 1521 1523 O
hepatitis 37 46 1524 1533 B-chronic_disease
B 47 48 1534 1535 I-chronic_disease
infection 49 58 1536 1545 O

Life 0 4 1546 1550 B-clinical_variable
expectancy 5 15 1551 1561 I-clinical_variable
of 16 18 1562 1564 O
at 19 21 1565 1567 O
least 22 27 1568 1573 O
6 28 29 1574 1575 B-lower_bound
months 30 36 1576 1582 I-lower_bound

Major 0 5 1583 1588 B-treatment
surgery 6 13 1589 1596 I-treatment
within 14 20 1597 1603 O
6 21 22 1604 1605 B-upper_bound
weeks 23 28 1606 1611 I-upper_bound
of 29 31 1612 1614 O
enrollment 32 42 1615 1625 O

PTT 0 3 1626 1629 B-clinical_variable
> 4 5 1630 1631 O
1.3 6 9 1632 1635 B-lower_bound
x 10 11 1636 1637 I-lower_bound
ULN 12 15 1638 1641 I-lower_bound

Platelet 0 8 1642 1650 B-clinical_variable
count 9 14 1651 1656 I-clinical_variable
< 15 16 1657 1658 O
100,000 17 24 1659 1666 B-upper_bound
/ 24 25 1666 1667 I-upper_bound
uL 25 27 1667 1669 I-upper_bound
without 28 35 1670 1677 O
full 36 40 1678 1682 O
- 40 41 1682 1683 O
dose 41 45 1683 1687 O
anticogulation 46 60 1688 1702 B-treatment
therapy 61 68 1703 1710 I-treatment

Platelet 0 8 1711 1719 B-clinical_variable
count 9 14 1720 1725 I-clinical_variable
< 15 16 1726 1727 O
150,000 17 24 1728 1735 O
/ 24 25 1735 1736 I-upper_bound
uL 25 27 1736 1738 I-upper_bound
with 28 32 1739 1743 O
ongoing 33 40 1744 1751 O
full 41 45 1752 1756 O
- 45 46 1756 1757 O
dose 46 50 1757 1761 O
anticoagulation 51 66 1762 1777 B-treatment
therapy 67 74 1778 1785 I-treatment

Pregnancy 0 9 1786 1795 B-pregnancy

Prior 0 5 1796 1801 B-treatment
external 6 14 1802 1810 I-treatment
beam 15 19 1811 1815 I-treatment
radiation 20 29 1816 1825 I-treatment
therapy 30 37 1826 1833 I-treatment
resulting 38 47 1834 1843 O
in 48 50 1844 1846 O
greater 51 58 1847 1854 O
than 59 63 1855 1859 O
20 64 66 1860 1862 B-lower_bound
% 66 67 1862 1863 I-lower_bound
total 68 73 1864 1869 O
bone 74 78 1870 1874 O
marrow 79 85 1875 1881 O
receiving 86 95 1882 1891 O
greater 96 103 1892 1899 O
than 104 108 1900 1904 O
20 109 111 1905 1907 B-lower_bound
Gy 112 114 1908 1910 I-lower_bound

Prior 0 5 1911 1916 B-treatment
radioisotope 6 18 1917 1929 I-treatment
therapy 19 26 1930 1937 I-treatment

Prior 0 5 1938 1943 B-treatment
total 6 11 1944 1949 I-treatment
body 12 16 1950 1954 I-treatment
or 17 19 1955 1957 O
hemi 20 24 1958 1962 B-treatment
- 24 25 1962 1963 I-treatment
body 25 29 1963 1967 I-treatment
irradiation 30 41 1968 1979 I-treatment

Prior 0 5 1980 1985 B-treatment
treatment 6 15 1986 1995 I-treatment
with 16 20 1996 2000 O
or 21 23 2001 2003 O
intolerance 24 35 2004 2015 O
to 36 38 2016 2018 O
proteasome 39 49 2019 2029 B-treatment
inhibitor 50 59 2030 2039 I-treatment
and 60 63 2040 2043 O
immunomodulator 64 79 2044 2059 B-treatment

Progressive 0 11 2060 2071 B-chronic_disease
disease 12 19 2072 2079 I-chronic_disease

Radiation 0 9 2080 2089 B-treatment
therapy 10 17 2090 2097 I-treatment
, 17 18 2097 2098 O
chemotherapy 19 31 2099 2111 B-treatment
, 31 32 2111 2112 O
immunotherapy 33 46 2113 2126 B-treatment
, 46 47 2126 2127 O
investigational 48 63 2128 2143 B-treatment
therapy 64 71 2144 2151 I-treatment
or 72 74 2152 2154 O
corticosteroid 75 89 2155 2169 B-treatment
use 90 93 2170 2173 O
within 94 100 2174 2180 O
2 101 102 2181 2182 B-upper_bound
weeks 103 108 2183 2188 I-upper_bound
of 109 111 2189 2191 O
or 112 114 2192 2194 O
after 115 120 2195 2200 O
eligibility 121 132 2201 2212 O
- 132 133 2212 2213 O
defining 133 141 2213 2221 O
bone 142 146 2222 2226 B-treatment
marrow 147 153 2227 2233 I-treatment
biopsy 154 160 2234 2240 I-treatment

Serum 0 5 2241 2246 B-clinical_variable
M 6 7 2247 2248 I-clinical_variable
- 7 8 2248 2249 I-clinical_variable
protein 8 15 2249 2256 I-clinical_variable
> 16 17 2257 2258 O
1 18 19 2259 2260 B-lower_bound
g 20 21 2261 2262 I-lower_bound
/ 21 22 2262 2263 I-lower_bound
dL 22 24 2263 2265 I-lower_bound

Serum 0 5 2266 2271 B-treatment
free 6 10 2272 2276 I-treatment
light 11 16 2277 2282 I-treatment
chain 17 22 2283 2288 I-treatment
( 23 24 2289 2290 I-treatment
FLC 24 27 2290 2293 I-treatment
) 27 28 2293 2294 I-treatment
assay 29 34 2295 2300 I-treatment

Urine 0 5 2301 2306 B-clinical_variable
M 6 7 2307 2308 I-clinical_variable
- 7 8 2308 2309 I-clinical_variable
protein 8 15 2309 2316 I-clinical_variable
> 16 17 2317 2318 O
200 18 21 2319 2322 B-lower_bound
mg/24h 22 28 2323 2329 I-lower_bound

WBC 0 3 2330 2333 B-clinical_variable
< 4 5 2334 2335 O
3000 6 10 2336 2340 B-upper_bound
/ 10 11 2340 2341 I-upper_bound
uL 11 13 2341 2343 I-upper_bound

Women 0 5 2344 2349 B-gender
of 6 8 2350 2352 O
childbearing 9 21 2353 2365 O
potential 22 31 2366 2375 O
and 32 35 2376 2379 O
men 36 39 2380 2383 O
who 40 43 2384 2387 O
are 44 47 2388 2391 O
able 48 52 2392 2396 O
to 53 55 2397 2399 O
father 56 62 2400 2406 O
a 63 64 2407 2408 O
child 65 70 2409 2414 O
, 70 71 2414 2415 O
must 72 76 2416 2420 O
agree 77 82 2421 2426 B-contraception_consent
to 83 85 2427 2429 I-contraception_consent
use 86 89 2430 2433 I-contraception_consent
an 90 92 2434 2436 I-contraception_consent
effective 93 102 2437 2446 I-contraception_consent
contraception 103 116 2447 2460 I-contraception_consent
method 117 123 2461 2467 I-contraception_consent
during 124 130 2468 2474 O
study 131 136 2475 2480 O
and 137 140 2481 2484 O
for 141 144 2485 2488 O
12 145 147 2489 2491 B-upper_bound
months 148 154 2492 2498 I-upper_bound
following 155 164 2499 2508 O
study 165 170 2509 2514 B-treatment
drug 171 175 2515 2519 I-treatment
administration 176 190 2520 2534 O

Women 0 5 2535 2540 B-gender
of 6 8 2541 2543 O
childbearing 9 21 2544 2556 O
potential 22 31 2557 2566 O
must 32 36 2567 2571 O
have 37 41 2572 2576 O
negative 42 50 2577 2585 B-pregnancy
pregnancy 51 60 2586 2595 I-pregnancy
test 61 65 2596 2600 O
within 66 72 2601 2607 O
24 73 75 2608 2610 B-upper_bound
hours 76 81 2611 2616 I-upper_bound
of 82 84 2617 2619 O
enrollment 85 95 2620 2630 O

absolute 0 8 2631 2639 B-clinical_variable
bone 9 13 2640 2644 I-clinical_variable
marrow 14 20 2645 2651 I-clinical_variable
plasma 21 27 2652 2658 I-clinical_variable
cell 28 32 2659 2663 I-clinical_variable
percentage 33 43 2664 2674 I-clinical_variable
must 44 48 2675 2679 O
be 49 51 2680 2682 O
> 52 53 2683 2684 O
or 54 56 2685 2687 O
equal 57 62 2688 2693 O
to 63 65 2694 2696 O
10 66 68 2697 2699 B-lower_bound
% 68 69 2699 2700 I-lower_bound
unless 70 76 2701 2707 O
prior 77 82 2708 2713 O
complete 83 91 2714 2722 O
response 92 100 2723 2731 O
when 101 105 2732 2736 O
absolute 106 114 2737 2745 O
bone 115 119 2746 2750 O
marrow 120 126 2751 2757 O
plasma 127 133 2758 2764 O
cell 134 138 2765 2769 O
percentage 139 149 2770 2780 O
must 150 154 2781 2785 O
be 155 157 2786 2788 O
> 158 159 2789 2790 O
or 160 162 2791 2793 O
equal 163 168 2794 2799 O
to 169 171 2800 2802 O
5 172 173 2803 2804 B-lower_bound
% 173 174 2804 2805 I-lower_bound

absolute 0 8 2806 2814 O
increase 9 17 2815 2823 O
in 18 20 2824 2826 O
serum 21 26 2827 2832 B-clinical_variable
M 27 28 2833 2834 I-clinical_variable
- 28 29 2834 2835 I-clinical_variable
protein 29 36 2835 2842 I-clinical_variable
of 37 39 2843 2845 O
> 40 41 2846 2847 O
or 42 44 2848 2850 O
equal 45 50 2851 2856 O
to 51 53 2857 2859 O
0.5 54 57 2860 2863 B-lower_bound
g 58 59 2864 2865 I-lower_bound
/ 59 60 2865 2866 I-lower_bound
dL 60 62 2866 2868 I-lower_bound

absolute 0 8 2869 2877 O
increase 9 17 2878 2886 O
in 18 20 2887 2889 O
urine 21 26 2890 2895 B-clinical_variable
M 27 28 2896 2897 I-clinical_variable
- 28 29 2897 2898 I-clinical_variable
protein 29 36 2898 2905 I-clinical_variable
of 37 39 2906 2908 O
> 40 41 2909 2910 O
or 42 44 2911 2913 O
equal 45 50 2914 2919 O
to 51 53 2920 2922 O
200 54 57 2923 2926 B-lower_bound
mg/24h 58 64 2927 2933 I-lower_bound

involved 0 8 2934 2942 O
FLC 9 12 2943 2946 B-clinical_variable
level 13 18 2947 2952 I-clinical_variable
> 19 20 2953 2954 O
or 21 23 2955 2957 O
equal 24 29 2958 2963 O
to 30 32 2964 2966 O
10 33 35 2967 2969 B-lower_bound
mg 36 38 2970 2972 I-lower_bound
/ 38 39 2972 2973 I-lower_bound
dL 39 41 2973 2975 I-lower_bound
provided 42 50 2976 2984 O
serum 51 56 2985 2990 B-clinical_variable
FLC 57 60 2991 2994 I-clinical_variable
ratio 61 66 2995 3000 I-clinical_variable
is 67 69 3001 3003 O
abnormal 70 78 3004 3012 O

low 0 3 3013 3016 O
- 3 4 3016 3017 O
dose 4 8 3017 3021 O
aspirin 9 16 3022 3029 B-treatment
for 17 20 3030 3033 O
cardioprotection 21 37 3034 3050 O

new 0 3 3051 3054 O
onset 4 9 3055 3060 O
hypercalcemia 10 23 3061 3074 B-clinical_variable
> 24 25 3075 3076 O
11.5 26 30 3077 3081 B-lower_bound
mg 31 33 3082 3084 I-lower_bound
/ 33 34 3084 3085 I-lower_bound
dL 34 36 3085 3087 I-lower_bound

